SEC Company Response from Protara Therapeutics, Inc. (TARA) (CIK 0001359931) (TARA) — Dec 18, 2019
Protara Therapeutics, Inc. (TARA) (CIK 0001359931)
Date: Dec. 18, 2019 · CIK: 0001359931 · Accession: 0001104659-19-073893
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234549
Letter
Proteon Therapeutics, Inc.
200 West Street
Waltham, MA 02451
December 18, 2019
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joseph McCann
Re: Proteon Therapeutics, Inc. Registration Statement on Form S-4 (File No. 333-234549)
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-234549) (the “Registration Statement”) of Proteon Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on December 19, 2018, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Tara McElhiney at (713) 890-5732.
[Remainder of page intentionally left blank]
Very truly yours,
Proteon Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm Proteon Therapeutics, Inc. 200 West Street Waltham, MA 02451 December 18, 2019 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joseph McCann Re: Proteon Therapeutics, Inc. Registration Statement on Form S-4 (File No. 333-234549) Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-234549) (the “Registration Statement”) of Proteon Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on December 19, 2018, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Tara McElhiney at (713) 890-5732. [Remainder of page intentionally left blank] Very truly yours, Proteon Therapeutics, Inc. By: /s/ George Eldridge George Eldridge, Senior Vice President, Chief Financial Officer, Treasurer and Assistant Secretary CC: Timothy P. Noyes, Proteon Therapeutics, Inc. Julio E. Vega, Morgan, Lewis & Bockius LLP Tara R. McElhiney, Morgan, Lewis & Bockius LLP Zachary E. Zemlin, Morgan, Lewis & Bockius LLP [Proteon Therapeutics, Inc. – Signature Page to Request for Acceleration]